Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1653 3791
This examiner grants 65% of resolved cases
Jennifer M.H. Tichy operates in Tech Center 3700 and Art Unit 1653. The examiner has managed 616 resolved cases, maintaining an allowance rate of 64.9%. The median days to allowance is 1088, which is a duration for prosecution in this unit. These metrics suggest an environment where grants are achieved in about 1088 days.
The interview lift is 34.5%, which is an increase over the 64.9% baseline. This suggests that interviews are effective for this examiner. For practitioners, the 34.5% lift indicates that direct communication is a tool for overcoming rejections. Given the 1088-day median pendency, an interview may also be a tool for moving the case toward a grant. With 616 resolved cases, the data provides a foundation for this strategy. Prioritizing an interview appears to be a way to navigate prosecution in Art Unit 1653 and improve the chances of success beyond the 64.9% baseline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18278719 | ASSEMBLED THREE-DIMENSIONAL CULTURES OF HUMAN NEURONS AND GLIA AND THEIR USE | Non-Final OA | The Regents of the University of California |
| 18018383 | NEW AGROCHEMICAL FORMULATIONS FOR FUSARICIDIN PRODUCING BACTERIA | Final Rejection | BASF SE |
| 16755226 | METHODS FOR INCREASING THE TOLERANCE OF MICROBIAL CELLS TOWARDS ANTHRANILIC ACID BY LIMITING THE AMOUNT OF AMMONIA IN THE CULTURE MEDIUM | Final Rejection | Covestro Deutschland AG |
| 17816924 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18780488 | Artificial tissue for transplantation therapy, drug screening, Manufacturing method thereof, and Manufacturing apparatus therefor | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18667066 | BACTERIA CLASSIFICATION AND ANALYSIS | Non-Final OA | SYSMEX CORPORATION |
| 17521410 | IDENTIFICATION OF MICROORGANISMS USING MALDI-TOF-MS ON-PLATE EXTRACTION | Non-Final OA | BECTON DICKINSON AND COMPANY |
| 18006413 | IN VIVO SCREENING ARRAY | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 18739556 | CELL SAMPLE MEASUREMENT METHOD AND CELL SAMPLE MEASUREMENT APPARATUS | Non-Final OA | Hamamatsu Photonics K.K. |
| 17615575 | PHARMACEUTICAL COMPOSITION COMPRISING GLIA-LIKE CELLS INDUCED FROM LATE PASSAGE HUMAN MESENCHYMAL STEM CELLS AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Final Rejection | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17783097 | Freeze-Dried Preparations Comprising Megakaryocytes and Platelets | Final Rejection | Kyoto University |
| 18063634 | CELL CULTURE BAG | Final Rejection | NAN YA PLASTICS CORPORATION |
| 18162777 | CELL LINES, SYSTEMS, KITS, AND METHODS FOR DETERMINING THE SPECIFICITY AND/OR POTENCY OF CERAMIDASE INHIBITORS | Non-Final OA | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. |
| 18282450 | PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN | Non-Final OA | Osaka University |
| 17386776 | DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME | Final Rejection | Osaka University |
| 17757356 | OPHTHALMOLOGICAL DEVICE FOR THE TREATMENT OF LSCD AND SUBSTRATE FOR USE IN SAME | Final Rejection | Universitair Ziekenhuis Antwerpen |
| 17921802 | COMPOSITIONS AND METHODS OF PROMOTING MYELINATION | Final Rejection | The Children's Medical Center Corporation |
| 17918093 | OSTEOBLASTS DIFFERENTIATED FROM MESENCHYMAL STEM CELLS AND COMPOSITION FOR TREATING BONE DISEASE COMPRISING SAME | Final Rejection | CEFO Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy